Cargando…

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma

Amplification of the MYCN gene leads to its overexpression at both the mRNA and protein levels. Overexpression of MYCN mRNA may also have an important role in promoting neuroblastoma (NB) beyond the translation of MYCN protein. In the present study, we report a small molecule compound (MX25-1) that...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tao, Gu, Lubing, Wu, Zhongzhi, Albadari, Najah, Li, Wei, Zhou, Muxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730801/
https://www.ncbi.nlm.nih.gov/pubmed/36505784
http://dx.doi.org/10.3389/fonc.2022.1058726
_version_ 1784845761851162624
author Liu, Tao
Gu, Lubing
Wu, Zhongzhi
Albadari, Najah
Li, Wei
Zhou, Muxiang
author_facet Liu, Tao
Gu, Lubing
Wu, Zhongzhi
Albadari, Najah
Li, Wei
Zhou, Muxiang
author_sort Liu, Tao
collection PubMed
description Amplification of the MYCN gene leads to its overexpression at both the mRNA and protein levels. Overexpression of MYCN mRNA may also have an important role in promoting neuroblastoma (NB) beyond the translation of MYCN protein. In the present study, we report a small molecule compound (MX25-1) that was able to bind to the 3’UTR of MYCN mRNA and induce MYCN mRNA degradation; this resulted in potent cell-growth inhibition and cell death specifically in MYCN-amplified or MYCN 3’UTR overexpressing NB cells. To evaluate the role of MYCN 3’UTR-mediated signals in contributing to the anticancer activity of MX25-1, we examined the status and activation of the tumor suppressor microRNA (miRNA) let-7, which is a target of MYCN 3’UTR in MYCN-amplified NB. We first observed that overexpression of MYCN mRNA was associated with high-level expression of the let-7 oncogenic targets DICER1, ARID3B and HMGA2. Following MYCN mRNA degradation, the expression of DICER1, ARID3B and HMGA2 was downregulated in MX25-1-treated cells. Inhibition of let-7 reversed the downregulation of these oncogenic mRNAs and significantly increased resistance of NB cells to MX25-1. Our results from this study supported the notion that overexpression of MYCN mRNA due to gene amplification has an independent function in NB cell growth and disease progression and suggest that targeting MYCN mRNA may represent an attractive strategy for therapy of MYCN amplified NB, both by inhibiting MYCN’s cell-survival effects and activating the tumor-suppressor effect of let-7.
format Online
Article
Text
id pubmed-9730801
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97308012022-12-09 MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma Liu, Tao Gu, Lubing Wu, Zhongzhi Albadari, Najah Li, Wei Zhou, Muxiang Front Oncol Oncology Amplification of the MYCN gene leads to its overexpression at both the mRNA and protein levels. Overexpression of MYCN mRNA may also have an important role in promoting neuroblastoma (NB) beyond the translation of MYCN protein. In the present study, we report a small molecule compound (MX25-1) that was able to bind to the 3’UTR of MYCN mRNA and induce MYCN mRNA degradation; this resulted in potent cell-growth inhibition and cell death specifically in MYCN-amplified or MYCN 3’UTR overexpressing NB cells. To evaluate the role of MYCN 3’UTR-mediated signals in contributing to the anticancer activity of MX25-1, we examined the status and activation of the tumor suppressor microRNA (miRNA) let-7, which is a target of MYCN 3’UTR in MYCN-amplified NB. We first observed that overexpression of MYCN mRNA was associated with high-level expression of the let-7 oncogenic targets DICER1, ARID3B and HMGA2. Following MYCN mRNA degradation, the expression of DICER1, ARID3B and HMGA2 was downregulated in MX25-1-treated cells. Inhibition of let-7 reversed the downregulation of these oncogenic mRNAs and significantly increased resistance of NB cells to MX25-1. Our results from this study supported the notion that overexpression of MYCN mRNA due to gene amplification has an independent function in NB cell growth and disease progression and suggest that targeting MYCN mRNA may represent an attractive strategy for therapy of MYCN amplified NB, both by inhibiting MYCN’s cell-survival effects and activating the tumor-suppressor effect of let-7. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9730801/ /pubmed/36505784 http://dx.doi.org/10.3389/fonc.2022.1058726 Text en Copyright © 2022 Liu, Gu, Wu, Albadari, Li and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Tao
Gu, Lubing
Wu, Zhongzhi
Albadari, Najah
Li, Wei
Zhou, Muxiang
MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
title MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
title_full MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
title_fullStr MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
title_full_unstemmed MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
title_short MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
title_sort mycn mrna degradation and cancer suppression by a selective small-molecule inhibitor in mycn-amplified neuroblastoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730801/
https://www.ncbi.nlm.nih.gov/pubmed/36505784
http://dx.doi.org/10.3389/fonc.2022.1058726
work_keys_str_mv AT liutao mycnmrnadegradationandcancersuppressionbyaselectivesmallmoleculeinhibitorinmycnamplifiedneuroblastoma
AT gulubing mycnmrnadegradationandcancersuppressionbyaselectivesmallmoleculeinhibitorinmycnamplifiedneuroblastoma
AT wuzhongzhi mycnmrnadegradationandcancersuppressionbyaselectivesmallmoleculeinhibitorinmycnamplifiedneuroblastoma
AT albadarinajah mycnmrnadegradationandcancersuppressionbyaselectivesmallmoleculeinhibitorinmycnamplifiedneuroblastoma
AT liwei mycnmrnadegradationandcancersuppressionbyaselectivesmallmoleculeinhibitorinmycnamplifiedneuroblastoma
AT zhoumuxiang mycnmrnadegradationandcancersuppressionbyaselectivesmallmoleculeinhibitorinmycnamplifiedneuroblastoma